News & Articles

ABLATOM deploys its LIBS microscope at the Grenoble Alpes University Hospital (CHUGA) to revolutionize patient diagnostics

Guest editorial article by Vikas Singh, PhD, and Thomas Beadnell, PhD, from Eurofins

Researchers’ time is heavily taxed by admin and compliance workflows, but digital records and easy access to asset data can help

Amp-Seq One offers reduced hands-on time and doubled throughput

Roche’s Elecsys Amyloid Plasma Panel shows high accuracy in ruling out Alzheimer's, offering new hope for early and less invasive diagnostics

Comprehensive digital guide to high-throughput screening (HTS) by cytometry, featuring assays, application data, and more

The EXENT System integrates immunoassay, MALDI-ToF mass spectrometry and intuitive data review software to provide enhanced analytical sensitivity and specificity for the measurement of monoclonal proteins

QIAstat-Dx Respiratory Panel Mini targets the five most actionable respiratory pathogens in outpatient settings to help clinicians make precise treatment decisions

Researchers funded by Cancer Research UK have made the biggest improvement in cervical cancer treatment in more than 20 years by changing how we use existing drugs

Florence Riaga discusses her working life and daily challenges as a TB nurse in Kenya

Explore the next-generation water purification system, the PURELAB flex from ELGA LabWater with sustainability at its core

With fewer side effects than traditional therapies, this innovative treatment could redefine care for patients facing limited options

Researchers have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer

This high-sensitivity troponin test from Siemens Healthineers is the only one in the US with a prognostic risk intended use

Learn more about the PathPresenter and Paige collaboration at an exclusive preconference workshop on November 3 at Pathology Visions 2024 conference

INTEGRA Biosciences supplies RAPT Therapeutics in San Francisco, USA, with pipettes to accelerate the development of its candidate small molecule inhibitors for the treatment of inflammatory diseases and cancers